MapLight Therapeutics, Inc. (MPLT)

NASDAQ: MPLT · Real-Time Price · USD

6.93

+0.71 (11.41%)

At close: Nov 6, 2026, 4:00 PM EST

7.10

+0.17 (2.45%)

After-hours: Nov 6, 2026, 7:52 PM EST

MapLight Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	71.63	46.73	38.25	79.77	27.67
Short-Term Investments	233.09	258.37	70.54	-	-
Cash & Short-Term Investments	304.73	305.1	108.8	79.77	27.67
Cash Growth	403.91%	180.44%	36.39%	188.34%	-
Prepaid Expenses	14.06	19.57	5.81	3.84	4.37
Total Current Assets	318.79	324.67	114.6	83.6	32.03
Property, Plant & Equipment	2.5	6.58	7.56	6.59	7.12
Long-Term Investments	46.62	147.99	11.38	0.99	-
Long-Term Deferred Charges	-	-	3	-	-
Other Long-Term Assets	0.45	0.27	0.37	0.23	0.23
Total Assets	368.35	479.51	136.92	91.41	39.39

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	2.05	3.29	1.91	3.25	3.6
Accrued Expenses	16.01	12.05	9.99	6.76	2.79
Current Portion of Leases	1.23	0.89	0.78	0.5	0.35
Current Unearned Revenue	-	-	3.24	4.2	5.86
Total Current Liabilities	19.29	16.23	15.92	14.7	12.6
Long-Term Leases	0.76	4.91	5.8	5.43	5.92
Total Liabilities	20.05	21.14	21.72	20.13	18.52

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0.01	0.01	-	-	-
Additional Paid-In Capital	830.62	819.12	5.58	4.2	3.12
Retained Earnings	-481.38	-360.52	-199.37	-121.79	-66.08
Comprehensive Income & Other	-0.94	-0.23	0.16	-	-
Total Common Equity	348.3	458.37	-193.63	-117.59	-62.96
Shareholders' Equity	348.3	458.37	115.2	71.28	20.87
Total Liabilities & Equity	368.35	479.51	136.92	91.41	39.39

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	1.99	5.8	6.58	5.92	6.27
Net Cash (Debt)	302.74	299.3	102.22	73.85	21.39
Net Cash Growth	457.87%	192.81%	38.42%	245.17%	-
Net Cash Per Share	9.77	34.48	138.85	111.94	38.41
Filing Date Shares Outstanding	46.38	44.02	0.76	0.67	0.56
Total Common Shares Outstanding	45.44	44.02	0.76	0.67	0.56
Working Capital	299.49	308.44	98.68	68.91	19.44
Book Value Per Share	7.67	10.41	-254.32	-176.19	-113.03
Tangible Book Value	348.3	458.37	-193.63	-117.59	-62.96
Tangible Book Value Per Share	7.67	10.41	-254.32	-176.19	-113.03
Machinery	-	3.69	3.25	2.77	2.22
Leasehold Improvements	-	-	-	0.01	-

SEC Filings: 10-K · 10-Q